MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program is drawing significant interest across the industry.
Month over Month Growth of 336% and 54% Reduction in Customer Acquisition Cost (CAC)
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Source: Original →